The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Scopolamine Transdermal Patch-Global Market Insights and Sales Trends 2024
Synopsis
Scopolamine is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics. It works by blocking the effects of a certain natural substance (acetylcholine) on the central nervous system.
The global Scopolamine Transdermal Patch market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Scopolamine Transdermal Patch in various end use industries. The expanding demands from the Motion Sickness, Nausea/Vomiting, Parkinsonian Tremor and Others, are propelling Scopolamine Transdermal Patch market. 1mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1.5mg segment is estimated at % CAGR for the next seven-year period.
Global Scopolamine market is projected to reach US$ 15 million in 2029, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Demand from Tablets and Injection are the major drivers for the industry.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Scopolamine Transdermal Patch, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Scopolamine Transdermal Patch market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Scopolamine Transdermal Patch market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Scopolamine Transdermal Patch sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Scopolamine Transdermal Patch covered in this report include Perrigo, Baxter, GSK, Mylan, Novartis and BengbuBBCATushan Pharmaceutical Co, etc.
The global Scopolamine Transdermal Patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perrigo
Baxter
GSK
Mylan
Novartis
BengbuBBCATushan Pharmaceutical Co
Global Scopolamine Transdermal Patch market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Scopolamine Transdermal Patch market, Segment by Type:
1mg
1.5mg
Global Scopolamine Transdermal Patch market, by Application
Motion Sickness
Nausea/Vomiting
Parkinsonian Tremor
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Scopolamine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Scopolamine is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics. It works by blocking the effects of a certain natural substance (acetylcholine) on the central nervous system.
The global Scopolamine Transdermal Patch market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Scopolamine Transdermal Patch in various end use industries. The expanding demands from the Motion Sickness, Nausea/Vomiting, Parkinsonian Tremor and Others, are propelling Scopolamine Transdermal Patch market. 1mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1.5mg segment is estimated at % CAGR for the next seven-year period.
Global Scopolamine market is projected to reach US$ 15 million in 2029, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Demand from Tablets and Injection are the major drivers for the industry.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Scopolamine Transdermal Patch, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Scopolamine Transdermal Patch market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Scopolamine Transdermal Patch market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Scopolamine Transdermal Patch sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Scopolamine Transdermal Patch covered in this report include Perrigo, Baxter, GSK, Mylan, Novartis and BengbuBBCATushan Pharmaceutical Co, etc.
The global Scopolamine Transdermal Patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perrigo
Baxter
GSK
Mylan
Novartis
BengbuBBCATushan Pharmaceutical Co
Global Scopolamine Transdermal Patch market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Scopolamine Transdermal Patch market, Segment by Type:
1mg
1.5mg
Global Scopolamine Transdermal Patch market, by Application
Motion Sickness
Nausea/Vomiting
Parkinsonian Tremor
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Scopolamine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Scopolamine Transdermal Patch Market Overview
1.1 Scopolamine Transdermal Patch Product Overview
1.2 Scopolamine Transdermal Patch Market Segment by Type
1.2.1 1mg
1.2.2 1.5mg
1.3 Global Scopolamine Transdermal Patch Market Size by Type
1.3.1 Global Scopolamine Transdermal Patch Market Size Overview by Type (2018-2029)
1.3.2 Global Scopolamine Transdermal Patch Historic Market Size Review by Type (2018-2023)
1.3.3 Global Scopolamine Transdermal Patch Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Scopolamine Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.2 Europe Scopolamine Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Scopolamine Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Scopolamine Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Scopolamine Transdermal Patch Sales Breakdown by Type (2018-2023)
2 Global Scopolamine Transdermal Patch Market Competition by Company
2.1 Global Top Players by Scopolamine Transdermal Patch Sales (2018-2023)
2.2 Global Top Players by Scopolamine Transdermal Patch Revenue (2018-2023)
2.3 Global Top Players by Scopolamine Transdermal Patch Price (2018-2023)
2.4 Global Top Manufacturers Scopolamine Transdermal Patch Manufacturing Base Distribution, Sales Area, Product Type
2.5 Scopolamine Transdermal Patch Market Competitive Situation and Trends
2.5.1 Scopolamine Transdermal Patch Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Scopolamine Transdermal Patch Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Scopolamine Transdermal Patch as of 2022)
2.7 Date of Key Manufacturers Enter into Scopolamine Transdermal Patch Market
2.8 Key Manufacturers Scopolamine Transdermal Patch Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Scopolamine Transdermal Patch Status and Outlook by Region
3.1 Global Scopolamine Transdermal Patch Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Scopolamine Transdermal Patch Historic Market Size by Region
3.2.1 Global Scopolamine Transdermal Patch Sales in Volume by Region (2018-2023)
3.2.2 Global Scopolamine Transdermal Patch Sales in Value by Region (2018-2023)
3.2.3 Global Scopolamine Transdermal Patch Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Scopolamine Transdermal Patch Forecasted Market Size by Region
3.3.1 Global Scopolamine Transdermal Patch Sales in Volume by Region (2024-2029)
3.3.2 Global Scopolamine Transdermal Patch Sales in Value by Region (2024-2029)
3.3.3 Global Scopolamine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Scopolamine Transdermal Patch by Application
4.1 Scopolamine Transdermal Patch Market Segment by Application
4.1.1 Motion Sickness
4.1.2 Nausea/Vomiting
4.1.3 Parkinsonian Tremor
4.1.4 Others
4.2 Global Scopolamine Transdermal Patch Market Size by Application
4.2.1 Global Scopolamine Transdermal Patch Market Size Overview by Application (2018-2029)
4.2.2 Global Scopolamine Transdermal Patch Historic Market Size Review by Application (2018-2023)
4.2.3 Global Scopolamine Transdermal Patch Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Scopolamine Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.2 Europe Scopolamine Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Scopolamine Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Scopolamine Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Scopolamine Transdermal Patch Sales Breakdown by Application (2018-2023)
5 North America Scopolamine Transdermal Patch by Country
5.1 North America Scopolamine Transdermal Patch Historic Market Size by Country
5.1.1 North America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Scopolamine Transdermal Patch Sales in Volume by Country (2018-2023)
5.1.3 North America Scopolamine Transdermal Patch Sales in Value by Country (2018-2023)
5.2 North America Scopolamine Transdermal Patch Forecasted Market Size by Country
5.2.1 North America Scopolamine Transdermal Patch Sales in Volume by Country (2024-2029)
5.2.2 North America Scopolamine Transdermal Patch Sales in Value by Country (2024-2029)
6 Europe Scopolamine Transdermal Patch by Country
6.1 Europe Scopolamine Transdermal Patch Historic Market Size by Country
6.1.1 Europe Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Scopolamine Transdermal Patch Sales in Volume by Country (2018-2023)
6.1.3 Europe Scopolamine Transdermal Patch Sales in Value by Country (2018-2023)
6.2 Europe Scopolamine Transdermal Patch Forecasted Market Size by Country
6.2.1 Europe Scopolamine Transdermal Patch Sales in Volume by Country (2024-2029)
6.2.2 Europe Scopolamine Transdermal Patch Sales in Value by Country (2024-2029)
7 Asia-Pacific Scopolamine Transdermal Patch by Region
7.1 Asia-Pacific Scopolamine Transdermal Patch Historic Market Size by Region
7.1.1 Asia-Pacific Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Scopolamine Transdermal Patch Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Scopolamine Transdermal Patch Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Scopolamine Transdermal Patch Forecasted Market Size by Region
7.2.1 Asia-Pacific Scopolamine Transdermal Patch Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Scopolamine Transdermal Patch Sales in Value by Region (2024-2029)
8 Latin America Scopolamine Transdermal Patch by Country
8.1 Latin America Scopolamine Transdermal Patch Historic Market Size by Country
8.1.1 Latin America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Scopolamine Transdermal Patch Sales in Volume by Country (2018-2023)
8.1.3 Latin America Scopolamine Transdermal Patch Sales in Value by Country (2018-2023)
8.2 Latin America Scopolamine Transdermal Patch Forecasted Market Size by Country
8.2.1 Latin America Scopolamine Transdermal Patch Sales in Volume by Country (2024-2029)
8.2.2 Latin America Scopolamine Transdermal Patch Sales in Value by Country (2024-2029)
9 Middle East and Africa Scopolamine Transdermal Patch by Country
9.1 Middle East and Africa Scopolamine Transdermal Patch Historic Market Size by Country
9.1.1 Middle East and Africa Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Scopolamine Transdermal Patch Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Scopolamine Transdermal Patch Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Scopolamine Transdermal Patch Forecasted Market Size by Country
9.2.1 Middle East and Africa Scopolamine Transdermal Patch Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Scopolamine Transdermal Patch Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Perrigo
10.1.1 Perrigo Company Information
10.1.2 Perrigo Introduction and Business Overview
10.1.3 Perrigo Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Perrigo Scopolamine Transdermal Patch Products Offered
10.1.5 Perrigo Recent Development
10.2 Baxter
10.2.1 Baxter Company Information
10.2.2 Baxter Introduction and Business Overview
10.2.3 Baxter Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Scopolamine Transdermal Patch Products Offered
10.2.5 Baxter Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Scopolamine Transdermal Patch Products Offered
10.3.5 GSK Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Scopolamine Transdermal Patch Products Offered
10.4.5 Mylan Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Scopolamine Transdermal Patch Products Offered
10.5.5 Novartis Recent Development
10.6 BengbuBBCATushan Pharmaceutical Co
10.6.1 BengbuBBCATushan Pharmaceutical Co Company Information
10.6.2 BengbuBBCATushan Pharmaceutical Co Introduction and Business Overview
10.6.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Products Offered
10.6.5 BengbuBBCATushan Pharmaceutical Co Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Scopolamine Transdermal Patch Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Scopolamine Transdermal Patch Industrial Chain Analysis
11.4 Scopolamine Transdermal Patch Market Dynamics
11.4.1 Scopolamine Transdermal Patch Industry Trends
11.4.2 Scopolamine Transdermal Patch Market Drivers
11.4.3 Scopolamine Transdermal Patch Market Challenges
11.4.4 Scopolamine Transdermal Patch Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Scopolamine Transdermal Patch Distributors
12.3 Scopolamine Transdermal Patch Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
